Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases
- Authors
-
-
Fabio Franceschini Mitri
Department of Human Anatomy, Institute of Biomedical Sciences, Federal University of Uberlandia, Uberlandia/MG, Brazil
-
- Keywords:
- Nanotechnology, Nanomedicine, Nanodrugs, Bone Cancer, Osteosarcoma, Bone Infection, Osteoarthritis, Targeted Delivery.
- Abstract
-
The ever-evolving field of nanotechnology has been applied over the years as an amazing potential tool in bone disorders through the development of targeted drug nanosystems. Bone diseases can be referred as any bone condition able to cause morbidity or even mortality to the host. Osteosarcoma has been most investigated condition for management and treatment by nanomedicine, and several nanomaterials such as nanoparticles, nanocapsules, nanospheres, nanodiamonds are being used for drug delivery. Likewise, other bone diseases, such as osteoporosis, osteonecrosis, osteoarthritis, bone tuberculosis have received nanotherapy with a large rate of success. The nanomedicine seems to make up a targeting lack by conventional therapy and chemotherapy, besides appointing to a trend of conservative clinical treatment, especially for severe disorders. Additionally, nanomedicine has advanced over the years, therefore, there is a strong need to accelerate its application in bone diseases reducing the mortality rate related to these conditions. This review article provides an overview on the advances of nanotechnology over the last two decades and highlights the pathways of investigations for targeted delivery nanoensembles.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 30-12-2021
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- Irfan Ahmad, Kundan Singh Chufal, Short Commentary: The Role of Thoracic Radiotherapy in Extensive Stage Small Cell Lung Carcinoma - A Concise Review of the Latest Literature , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Wifaq Siam, Mona Ellaithi, Hind M. AbuShama, Abdulrahman Mujalli, Shakir Idris, Alaa Siddiq, Osama Mohamed Khair, Dania A. Albader, Faris M. Elmahdi, Clinicopathological Features and RB1 Gene Polymorphism in Sudanese Retinoblastoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- S. Simonida Crvenkova, Maja Popova, Concomitant Treatment for Brain Metastases in Non-Small Cell Lung Cancer Patients: Our Clinical Experience , Journal of Cancer Research Updates: Vol. 5 No. 1 (2016)
- Tibor Hajto, Angelika Kirsch, Case Reports of Cancer Patients with Hepatic Metastases Treated by Standardized Plant Immunomodulatory Preparations , Journal of Cancer Research Updates: Vol. 2 No. 1 (2013)
- R. Hsieh, M.L. Prasad, M.M.S. Nico, H. Tavares, A. Altemani, R.S.S. Macarenco, S.V. Lourenço, A Study of C-MYC, SOX10 and BCL-2 Proteins Expression in Head and Neck Mucosal Melanomas , Journal of Cancer Research Updates: Vol. 5 No. 4 (2016)
- Tatjana P. Stanojkovic, Sanja Milovic, A Marine Natural Products as Modulators of Multidrug Resistance , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Kunal M. Tewari, Suneela S. Dhaneshwar, Inhibitors of Apoptosis Proteins (IAPs): Clinical Significance in Cancer Treatment Research , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- K. Pawinska-Wasikowska, T. Ksiazek, A. Wieczorek, M. Matysiak, B. Fic-Sikorska, E. Adamkiewicz-Drozynska, L. Maciejka-Kapuscinska, A. Chybicka, K. Potocka, J. Wachowiak, J. Skalska-Sadowska, J. Kowalczyk, B. Wojcik, M. Wysocki, S. Koltan, M. Krawczuk-Rybak, K. Muszynska-Roslan, W. Mlynarski, M. Stolarska, T. Urasinski, E. Kamienska, T. Szczepanski, R. Tomaszewska, G. Sobol-Milejska, A. Mizia-Malarz, G. Karolczyk, J. Pohorecka, M. Wieczorek, I. Karpinska-Derda, W. Balwierz, Is FLT3 Internal Tandem Duplication an Unfavorable Risk Factor for High Risk Children with Acute Myeloid Leukemia? - Polish Experience , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Wenying Zhang, Hui Di, Renpei Xia, Jiali Yang, Junfeng Zhang, Jianyou Gu, PSMD14 Drives Clear Cell Renal Cell Carcinoma Progression via JAK/STAT3 Signaling , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- Sana Belkahla, Dichloroacetate Reprograms JunD Expression and Enhances Chemosensitivity in Acute Myeloid Leukemia via p53 Status , Journal of Cancer Research Updates: Vol. 15 No. 2 (2026)
You may also start an advanced similarity search for this article.